s6y

ANADYS PHARMACEUTICALS INC

CIK
1128495
Industry
Pharmaceutical Preparations

Financials 31

  1. 10-Q Quarterly Report for period ending Sep 30, 2011
  2. 10-Q Quarterly Report for period ending Jun 30, 2011
  3. 10-Q Quarterly Report for period ending Mar 31, 2011
  4. 10-K Annual Report for period ending Dec 31, 2010
  5. 10-Q Quarterly Report for period ending Sep 30, 2010
  6. 10-Q Quarterly Report for period ending Jun 30, 2010
  7. 10-Q Quarterly Report for period ending Mar 31, 2010
  8. 10-K Annual Report for period ending Dec 31, 2009
  9. 10-Q Quarterly Report for period ending Sep 30, 2009
  10. 10-Q Quarterly Report for period ending Jun 30, 2009

All 31 financials filings

News 80

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 80 news filings

Ownership 317

  1. SC 13G/A Major Shareholders
  2. SC 13G/A Major Shareholders
  3. SC 13G/A Major Shareholders
  4. SC 13D/A Major Shareholders
  5. SC 13D/A Major Shareholders
  6. SC 13D Major Shareholders
  7. SC 13D/A Major Shareholders
  8. 4 Statement of changes in beneficial ownership of securities
  9. SC 13D/A Major Shareholders
  10. 4 Statement of changes in beneficial ownership of securities

All 317 ownership filings

Prospectus 41

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 POS Post-effective amendment to a S-8 registration statement
  7. S-8 POS Post-effective amendment to a S-8 registration statement
  8. S-8 POS Post-effective amendment to a S-8 registration statement
  9. SC TO-T/A Third party tender offer statement
  10. SC TO-T/A Third party tender offer statement

All 41 prospectus filings

Proxies 7

  1. DEF 14A Definitive proxy statements
  2. DEF 14A Definitive proxy statements
  3. DEF 14A Definitive proxy statements
  4. DEF 14A Definitive proxy statements
  5. DEF 14A Definitive proxy statements
  6. DEF 14A Definitive proxy statements
  7. DEF 14A Definitive proxy statements

Other 44

  1. EFFECT Notice of Effectiveness
  2. EFFECT Notice of Effectiveness
  3. EFFECT Notice of Effectiveness
  4. EFFECT Notice of Effectiveness
  5. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  6. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  7. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  8. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  9. POS AM Post-effective amendment to a registration statement that is not immediately effective upon filing
  10. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

All 44 other filings